Small and Medium-sized Enterprises
The SME (Small and Medium-sized Enterprises) status is recognised by the EMA to support smaller companies in drug development. It provides financial (fee reductions), administrative, and regulatory incentives. This framework fosters innovation and helps emerging biotechs access European marketing authorisation procedures more easily.
